Riskpilot← Back to searchSign inGet full accessCYTOVAC A/S
A/SBankruptCVR 31262666Frederiksgade 19, 3.Research and experimental development on natural sciences and engineering · NACE 7210Est. 20082 employees
Revenue 2023
—
EBITDA margin
—
-22% vs 2022
Equity ratio
-1378.2%
Financial strength
Net profit 2023
DKK -15,3M
-144% vs 2022
| Revenue | — | — |
| EBITDA | DKK -12,2M | -22% |
| Net profit | DKK -15,3M | -144% |
| Total assets | DKK 6,4M | +99% |
| Equity | DKK -88,6M | -21% |
| Employees | 2 | — |
Legal name
CYTOVAC A/S
CVR number
31262666
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. februar 2008
Share capital
DKK 100.540.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af et medlem af bestyrelsen i forening med selskabets direktør.
Address
Frederiksgade 19, 3.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -5.241 | -6.551 | -8.078 | -9.152 | -9.088 | -11.513 | — | — | 1.000 | 960 | 0 | — |
| Staff expenses | -6.561 | -5.353 | -5.849 | -6.448 | -6.567 | -7.062 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -11.801 | -11.904 | -13.927 | -15.600 | -15.655 | -18.576 | -35.681 | -37.591 | -13.507 | -13.049 | -10.043 | -12.227 |
| Depreciation & amort. | -388 | -236 | -407 | -482 | -522 | -504 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -12.189 | -12.139 | -14.334 | -16.082 | -16.177 | -19.080 | -35.681 | -37.591 | -13.507 | -13.049 | -10.043 | -12.227 |
| Net financials | 12 | 6 | 51 | 3 | -2 | -3 | -171 | -2.051 | -4.319 | -1.993 | 2.342 | -4.893 |
| Profit before tax | -12.177 | -12.133 | -14.283 | -16.079 | -16.179 | -19.083 | -35.852 | -39.642 | -17.826 | -15.042 | -7.701 | -17.120 |
| Tax | -1.250 | -1.250 | -3.499 | -3.851 | -3.495 | -4.226 | -5.500 | -5.500 | -2.130 | -1.690 | -1.424 | -1.801 |
| Net profit | -10.927 | -10.883 | -10.783 | -12.228 | -12.683 | -14.857 | -30.352 | -34.142 | -15.696 | -13.352 | -6.277 | -15.319 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 15.294 | 29.033 | 20.248 | 8.572 | 11.777 | 6.590 | 9.573 | 7.504 | 3.513 | 2.976 | 3.225 | 6.427 |
| Equity | 12.830 | 1.947 | 18.150 | 5.922 | 9.275 | 3.519 | -3.793 | -37.935 | -53.631 | -66.983 | -73.260 | -88.579 |
| Long-term debt | 0 | 25.111 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 619 | 639 | 662 |
| Short-term debt | 2.464 | 1.975 | 2.099 | 2.650 | 2.501 | 2.971 | 13.366 | 45.439 | 57.144 | 69.339 | 75.845 | 94.345 |
| Total debt | 2.464 | 27.086 | 2.099 | 2.650 | 2.501 | 2.971 | 13.366 | 45.439 | 57.144 | 69.339 | 76.484 | 95.007 |
EBITDA margin
-1222700000.0%
This company
15.8%
Market median
-7738607695% vs market
20122023
Equity ratio
-1378.2%
This company
38.2%
Market median
-3708% vs market
20122023
Return on equity
-1531900000.0%
This company
18.4%
Market median
-8325543578% vs market
20122023
Net profit margin
-1531900000.0%
This company
8.1%
Market median
-18912345779% vs market
20122023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122023
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
20122023
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MR Management | Management | 2008 | — | — |
LD Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
JA Management | Management | 2008 | — | — |
PF Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
KA Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2009 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2011 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 5.0% | 5.0% | 2014 | |
GERT TOFTKJÆR ApS | Company | 5.0% | 5.0% | 2013 |
BAIAS ApS | Company | 5.0% | 5.0% | 2018 |
JAKOBS HUS ApS | Company | 15.0% | 15.0% | 2018 |
| Individual | 100.0% | 100.0% | 2019 | |
| Individual | 5.0% | 5.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CYTOVAC A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Roland Jensen | Management | 0 companies |
| Lone Dahl Andersen | Chief Executive Officer | 0 companies |
| Janet Alsø | Management | 0 companies |
| Per Falholt | Chief Executive Officer | 0 companies |
| Kim Arvid Nielsen | Chief Executive Officer | 0 companies |
| Inge Alsø | Board of Directors | 0 companies |
| Hans Christian Petersen | Board of Directors | 0 companies |
| Lars Peter Bjerrek | Board of Directors | 0 companies |
| Jarne Elleholm | Board of Directors | 0 companies |
| Lars-Christian Brask | Board of Directors | 0 companies |
| Pia Lolk Wolff-Sneedorff | Board of Directors | 0 companies |
| Peter Bonne Eriksen | Board of Directors | 0 companies |
| Gert Toftkjær | Board of Directors | 0 companies |
| Jan Kuhlmann Andersen | Chairman | 0 companies |
| Karine Djandjougazian | Board of Directors | 0 companies |
| Ole Sylvester-Hvid Wiborg | Board of Directors | 0 companies |
| Frederik Franz Johan Wilhelm Buch | Board of Directors | 0 companies |
| Alexei Kirkine | Board of Directors | 0 companies |
| Claus Toftkjær | Board of Directors | 0 companies |
| Jørgen Kirkegaard Kimø | Board of Directors | 0 companies |
| Bent Alsø | Board of Directors | 0 companies |